Results Wire: US FDA Advisory Committee Vote Does Not Favor Approval of Aradigm’s Linhaliq, a Ciprofloxacin Inhalation Powder Report
Results Wire: US FDA Advisory Committee Vote Does Not Favor Approval of Aradigm’s Linhaliq, a Ciprofloxacin Inhalation Powder Report